Madhya Pradesh: DRI seizes 112 kg Mephedrone

• 14 Oct 2024

Why in News?  

Recently, the Directorate of Revenue Intelligence (DRI) busted an illegal mephedrone factory in Jhabua, Madhya Pradesh, seizing a large quantity of narcotics.

Key Points  

• DRI Operation in Jhabua: The Directorate of Revenue Intelligence (DRI) uncovered an illegal factory manufacturing mephedrone in Jhabua, Madhya Pradesh. 
  • The operation led to the seizure of 112 kg of mephedrone, a synthetic drug, with a high street value. 
  • Multiple individuals involved in the illegal drug manufacturing and distribution network were arrested during the operation. 
• Impact on Drug Trafficking: The bust is considered a significant blow to narcotics trafficking in the region, as mephedrone is a popular illegal drug in the market. 
• Continued Vigilance: Authorities have increased vigilance and are monitoring the area to prevent further illegal drug activities in the region. 
• Mephedrone and its Risks: Mephedrone, also known as "meow meow" or "MD," is a highly addictive synthetic drug, with severe health risks, making its illegal production a priority for law enforcement to tackle. 

Mephedrone

• It is also known as 4-methylmethcathinone, 4-MMC and 4-methylephedrone. 
• It is a synthetic stimulant drug of the amphetamine and cathinone classes. 
• Other names: drone, M-CAT, white magic, ‘meow meow’, and bubble. 
• It has a role as a xenobiotic and an environmental contaminant. 
• It has been linked to a range of adverse effects on both physical and mental health. 
• Users commonly report increased alertness, euphoria, and enhanced sociability, but these positive effects come at a cost. 
• Health impacts: 
  • Anxiety, paranoia, nausea, and insomnia are among the negative side effects experienced by individuals under the influence of this synthetic stimulant. 
  • Prolonged use of Mephedrone has been associated with more severe consequences, including cardiovascular issues, hallucinations, and even instances of aggressive behaviour. 
  • The drug's impact on mental health raises concerns about its potential for addiction and long-term psychological harm. 
• It is banned in India under the Narcotic Drugs and Psychotropic Substances Act, 1985.